Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RYTM Rhythm Pharmaceuticals Inc.

盘前交易 07-19 09:15:35 EDT

49.26

-2.82

-5.41%

最高52.21	最低48.31	成交量38.73万
今开52.00	昨收52.08	日振幅7.49%
总市值30.04亿	流通市值22.46亿	总股本6,097万
成交额1,919万	换手率0.85%	流通股本4,560万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RYTM","market":"US","secType":"STK","nameCN":"Rhythm Pharmaceuticals Inc.","latestPrice":49.26,"timestamp":1721332800000,"preClose":52.08,"halted":0,"volume":387272,"delay":0,"floatShares":45595815,"shares":60972909,"eps":-4.679014,"marketStatus":"盘前交易","marketStatusCode":1,"change":-2.82,"latestTime":"07-19 09:15:35 EDT","open":52,"high":52.21,"low":48.31,"amount":19186075.677016,"amplitude":0.074885,"askPrice":58.17,"askSize":7,"bidPrice":48,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-4.679014,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721395800000},"adr":0,"listingDate":1507176000000,"adjPreClose":49.26,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":49.26,"preClose":49.26,"latestTime":"17:02 EDT","volume":39415,"amount":1941592.87,"timestamp":1721336548274},"volumeRatio":0.571029531828438,"impliedVol":0.5893,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/RYTM","defaultTab":"news","newsList":[{"id":"2452963439","title":"Rhythm Pharmaceuticals, Inc.盘中异动 股价大跌5.06%报49.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452963439","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452963439?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:06","pubTimestamp":1721318773,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时06分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.06%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.27%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2276.14%、2214.09%、1188.94%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719000613941f8616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719000613941f8616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","RYTM"],"gpt_icon":0},{"id":"2450139325","title":"Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450139325","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450139325?lang=zh_cn&edition=full","pubTime":"2024-07-12 00:31","pubTimestamp":1720715488,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日00时31分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.09%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。消息层面，截至00时31分，《富国集团维持Rhythm Pharmaceuticals买入评级，维持目标价52美元》资讯为影响Rhythm Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120031299681c10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120031299681c10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4139","BK4588"],"gpt_icon":0},{"id":"2448946782","title":"Rhythm Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.21%报43.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448946782","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448946782?lang=zh_cn&edition=full","pubTime":"2024-07-02 02:09","pubTimestamp":1719857356,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日02时09分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.21%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Seastar Medical Holding Corporation涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为752.28%、199.37%、121.90%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、75.31%、56.57%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702020916941f2cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702020916941f2cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","RYTM","BK4585"],"gpt_icon":0},{"id":"2444964921","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%报40.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444964921","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444964921?lang=zh_cn&edition=full","pubTime":"2024-06-17 23:14","pubTimestamp":1718637296,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日23时14分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.00%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biorestorative Therapies, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4465.79%、1486.65%、149.14%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.，振幅分别为170.77%、53.30%、29.99%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617231456941ef00b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617231456941ef00b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2443658761","title":"Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨5.16%报44.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443658761","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443658761?lang=zh_cn&edition=full","pubTime":"2024-06-14 03:55","pubTimestamp":1718308529,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日03时55分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.16%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Biorestorative Therapies, Inc.涨幅较大，Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2990.60%、1367.33%、164.18%，振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为102.21%、84.09%、74.62%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614035530aef4d8d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614035530aef4d8d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4588","LGVN","BK4139","BK4585"],"gpt_icon":0},{"id":"2442550601","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442550601","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442550601?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:12","pubTimestamp":1718201572,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时12分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.06%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为71.89%、28.90%、9.69%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为84.47%、52.63%、51.41%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612221252af8d314c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612221252af8d314c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RYTM","BK4585","BK4139"],"gpt_icon":0},{"id":"2435135608","title":"Rhythm Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.41亿美元，同比减少170.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435135608","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435135608?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:13","pubTimestamp":1715530405,"startTime":"0","endTime":"0","summary":"3月31日，Rhythm Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.41亿美元，同比减少170.22%；其中营业收入为25.97百万美元，同比增加126.42%，每股基本收益为-2.35美元。机构评级：截至2024年3月31日，当前有9家机构对Rhythm Pharmaceuticals, Inc.目标价做出预测，其中目标均价为57.22美元，其中最低目标价为42.00美元，最高目标价为79.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130013318afe8d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130013318afe8d1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2433172143","title":"Rhythm Pharmaceuticals, Inc.盘中异动 快速下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433172143","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433172143?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:35","pubTimestamp":1715175332,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.18%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。该信息摘要如下：Needham：维持Rhythm Pharmaceuticals评级，由买入调整至买入评级, 目标价由50.00美元调整至46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","RYTM"],"gpt_icon":0},{"id":"2433334427","title":"Rhythm Pharmaceuticals Inc 报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433334427","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433334427?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:47","pubTimestamp":1715104049,"startTime":"0","endTime":"0","summary":"   * Rhythm Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损2.35美元，低于去年同期的每股收益-92美分。九位分析师对该季度的平均预期是每股亏损 2.16 美元。华尔街预期为每股亏损 2.41 美元至-61 美分。* Rhythm Pharmaceuticals Inc 公布的本季度每股收益为亏损 2.35 美元。* 该公司一季度亏损 1.4137 亿美元。* Rhythm Pharmaceuticals Inc 本季度股价上涨了 1.3%，今年迄今为止亏损了 4.5%。华尔街对 Rhythm Pharmaceuticals Inc 的 12 个月目标价中位数为 55.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","RYTM","BK4139","BK4585"],"gpt_icon":0},{"id":"2433578826","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大跌9.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433578826","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433578826?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:32","pubTimestamp":1715088734,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时32分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价急速下跌9.71%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nanoviricides, Inc.涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为843.97%、93.56%、31.28%，振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Bio-Path Holdings, Inc.，振幅分别为14.53%、12.14%、8.85%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721321487dc9df6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721321487dc9df6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2432904876","title":"Rhythm Pharmaceuticals Inc    预计每股亏损 2.16 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432904876","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432904876?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:05","pubTimestamp":1714748723,"startTime":"0","endTime":"0","summary":"   * Rhythm Pharmaceuticals Inc    将于5月7日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收预计将从去年同期的1147万美元增长134.5%，达到2689.6万美元。* LSEG 分析师对 Rhythm Pharmaceuticals Inc 的平均预期是每股亏损 2.16 美元。* 华尔街对 Rhythm Pharmaceuticals Inc 的 12 个月目标价中值为 55.00 美元，高于其上一次收盘价 40.98 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYTM"],"gpt_icon":0},{"id":"2432004306","title":"Rhythm Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432004306","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432004306?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:21","pubTimestamp":1714497670,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日01时21分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.41%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1481.84%、232.31%、28.17%，振幅较大的相关个股有Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为55.38%、48.00%、46.79%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010121117a57c9e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010121117a57c9e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","RYTM","BK4585"],"gpt_icon":0},{"id":"2430281281","title":"Rhythm Pharmaceuticals, Inc.盘中异动 快速下跌5.01%报37.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281281","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430281281?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:44","pubTimestamp":1714052661,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时44分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.01%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1095.74%、190.10%、7.73%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521442287e83b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521442287e83b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","RYTM","BK4585"],"gpt_icon":0},{"id":"2429953115","title":"Rhythm Pharmaceuticals, Inc.盘中异动 快速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429953115","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429953115?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:31","pubTimestamp":1713882681,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时31分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.23%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Palisade Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2269.57%、174.35%、33.43%，振幅较大的相关个股有Palisade Bio, Inc.、Moolec Science Sa C/Wts 、Immunitybio, Inc.，振幅分别为37.32%、35.00%、27.32%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223121861e8341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223121861e8341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RYTM","BK4585","BK4139"],"gpt_icon":0},{"id":"2428591553","title":"富国银行：维持Rhythm Pharmaceuticals(RYTM.US)评级，由增持调整至增持评级, 目标价由53.00美元调整至52.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591553","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428591553?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:06","pubTimestamp":1713445594,"startTime":"0","endTime":"0","summary":"富国银行：维持Rhythm Pharmaceuticals(RYTM.US)评级，由增持调整至增持评级, 目标价由53.00美元调整至52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182106368b36273f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182106368b36273f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2427590487","title":"Rhythm Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427590487","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427590487?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:46","pubTimestamp":1712947575,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时46分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.03%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3680.11%、1451.48%、105.52%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc是一家生物制药公司。该信息摘要如下：Needham：重申Rhythm Pharmaceuticals评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041302461579204092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041302461579204092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","RYTM","BK4139"],"gpt_icon":0},{"id":"2426497532","title":"Rhythm Pharmaceuticals, Inc.盘中异动 急速跳水6.05%报40.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426497532","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426497532?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755849,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价快速跳水6.05%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Vbi Vaccines, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为753.89%、61.90%、20.41%，振幅较大的相关个股有Foghorn Therapeutics Inc.、Adial Pharmaceuticals, Inc、Century Therapeutics, Inc.，振幅分别为9.52%、7.96%、7.73%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc是一家生物制药公司。该信息摘要如下：Needham：重申Rhythm Pharmaceuticals评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213049791faba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213049791faba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","RYTM","BK4588"],"gpt_icon":0},{"id":"2426446645","title":"Needham：重申Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426446645","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426446645?lang=zh_cn&edition=full","pubTime":"2024-04-10 18:35","pubTimestamp":1712745348,"startTime":"0","endTime":"0","summary":"Needham：重申Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041018354987608702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041018354987608702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2424076123","title":"Rhythm Pharmaceuticals, Inc.盘中异动 大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424076123","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424076123?lang=zh_cn&edition=full","pubTime":"2024-04-03 02:46","pubTimestamp":1712083562,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日02时46分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报40.53美元/股，成交量22.9279万股，换手率0.38%，振幅3.56%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Gamida Cell Ltd.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Q32 Bio Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为928.67%、162.96%、67.50%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Gamida Cell Ltd.，振幅分别为104.31%、67.61%、61.39%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403024602861e3115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403024602861e3115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2422577919","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422577919","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422577919?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:56","pubTimestamp":1711551402,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时56分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.36%。截至发稿，该股报41.65美元/股，成交量12.5355万股，换手率0.21%，振幅4.81%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为2825.46%、1099.92%、60.08%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Stoke Therapeutics, Inc.，振幅分别为86.96%、77.40%、58.70%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327225642791d4f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327225642791d4f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RYTM","BK4585","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rhythmtx.com","stockEarnings":[{"period":"1week","weight":0.0571},{"period":"1month","weight":0.1901},{"period":"3month","weight":0.296},{"period":"6month","weight":0.2003},{"period":"1year","weight":1.8132},{"period":"ytd","weight":0.0716}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.1161},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rhythm Pharmaceuticals, Inc.是一家特拉华州的公司，成立于2013年2月。该公司是一家全球性、商业阶段的生物制药公司，致力于改变患有罕见神经内分泌疾病的患者及其家人的生活。该公司专注于推进黑皮质素-4受体激动剂，包括他们的主要资产IMCIVREE，作为一种精准药物，旨在治疗由罕见的MC4R通路疾病引起的食欲亢进和严重肥胖。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.069511},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.038439},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.058938},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.006165},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.0624},{"month":6,"riseRate":0.428571,"avgChangeRate":0.04883},{"month":7,"riseRate":0.428571,"avgChangeRate":0.275801},{"month":8,"riseRate":0.833333,"avgChangeRate":0.287356},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.068605},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.026435},{"month":11,"riseRate":0.857143,"avgChangeRate":0.139176},{"month":12,"riseRate":0.714286,"avgChangeRate":0.069762}],"exchange":"NASDAQ","name":"Rhythm Pharmaceuticals Inc.","nameEN":"Rhythm Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rhythm Pharmaceuticals Inc.,RYTM,Rhythm Pharmaceuticals Inc.股票,Rhythm Pharmaceuticals Inc.股票老虎,Rhythm Pharmaceuticals Inc.股票老虎国际,Rhythm Pharmaceuticals Inc.行情,Rhythm Pharmaceuticals Inc.股票行情,Rhythm Pharmaceuticals Inc.股价,Rhythm Pharmaceuticals Inc.股市,Rhythm Pharmaceuticals Inc.股票价格,Rhythm Pharmaceuticals Inc.股票交易,Rhythm Pharmaceuticals Inc.股票购买,Rhythm Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}